246 related articles for article (PubMed ID: 23891296)
21. Whole-body MR imaging: evaluation of patients for metastases.
Lauenstein TC; Goehde SC; Herborn CU; Goyen M; Oberhoff C; Debatin JF; Ruehm SG; Barkhausen J
Radiology; 2004 Oct; 233(1):139-48. PubMed ID: 15317952
[TBL] [Abstract][Full Text] [Related]
22. Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres.
Paprottka PM; Hoffmann RT; Haug A; Sommer WH; Raessler F; Trumm CG; Schmidt GP; Ashoori N; Reiser MF; Jakobs TF
Cardiovasc Intervent Radiol; 2012 Apr; 35(2):334-42. PubMed ID: 21847708
[TBL] [Abstract][Full Text] [Related]
23. Fluid-fluid level in hepatic metastases: a characteristic sign of metastases of neuroendocrine origin.
Sommer WH; Zech CJ; Bamberg F; Auernhammer CJ; Helck A; Paprottka PM; Notohamiprodjo M; Reiser MF; Herrmann KA
Eur J Radiol; 2012 Sep; 81(9):2127-32. PubMed ID: 21978774
[TBL] [Abstract][Full Text] [Related]
24. ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.
Tachezy M; Zander H; Marx AH; Gebauer F; Rawnaq T; Kaifi JT; Sauter G; Izbicki JR; Bockhorn M
J Surg Res; 2011 Oct; 170(2):226-32. PubMed ID: 21816425
[TBL] [Abstract][Full Text] [Related]
25. Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients.
Klingenstein A; Haug AR; Zech CJ; Schaller UC
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):158-65. PubMed ID: 22526099
[TBL] [Abstract][Full Text] [Related]
26. Perilesional enhancement of hepatic metastases: correlation between MR imaging and histopathologic findings-initial observations.
Semelka RC; Hussain SM; Marcos HB; Woosley JT
Radiology; 2000 Apr; 215(1):89-94. PubMed ID: 10751472
[TBL] [Abstract][Full Text] [Related]
27. Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors.
Boyar Cetinkaya R; Vatn M; Aabakken L; Bergestuen DS; Thiis-Evensen E
Scand J Gastroenterol; 2014 Jun; 49(6):734-41. PubMed ID: 24679166
[TBL] [Abstract][Full Text] [Related]
28. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
29. Downstaging chemotherapy and alteration in the classic computed tomography/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors: influence on patient selection for surgery.
Donahue TR; Isacoff WH; Hines OJ; Tomlinson JS; Farrell JJ; Bhat YM; Garon E; Clerkin B; Reber HA
Arch Surg; 2011 Jul; 146(7):836-43. PubMed ID: 21768431
[TBL] [Abstract][Full Text] [Related]
30. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
Auernhammer CJ; Jauch KW; Hoffmann JN
Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic neuroendocrine tumors.
Perri G; Prakash LR; Katz MHG
Curr Opin Gastroenterol; 2019 Sep; 35(5):468-477. PubMed ID: 31306159
[TBL] [Abstract][Full Text] [Related]
32. High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria.
Stacchiotti S; Collini P; Messina A; Morosi C; Barisella M; Bertulli R; Piovesan C; Dileo P; Torri V; Gronchi A; Casali PG
Radiology; 2009 May; 251(2):447-56. PubMed ID: 19261927
[TBL] [Abstract][Full Text] [Related]
33. Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison.
Marcos HB; Libutti SK; Alexander HR; Lubensky IA; Bartlett DL; Walther MM; Linehan WM; Glenn GM; Choyke PL
Radiology; 2002 Dec; 225(3):751-8. PubMed ID: 12461257
[TBL] [Abstract][Full Text] [Related]
34. Dynamic contrast-enhanced MRI of neuroendocrine hepatic metastases: A feasibility study using a dual-input two-compartment model.
Koh TS; Thng CH; Hartono S; Kwek JW; Khoo JB; Miyazaki K; Collins DJ; Orton MR; Leach MO; Lewington V; Koh DM
Magn Reson Med; 2011 Jan; 65(1):250-60. PubMed ID: 20860001
[TBL] [Abstract][Full Text] [Related]
35. Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management.
Sahani DV; Bonaffini PA; Fernández-Del Castillo C; Blake MA
Radiology; 2013 Jan; 266(1):38-61. PubMed ID: 23264526
[TBL] [Abstract][Full Text] [Related]
36. [Liver transplantation in neuroendocrine tumors prolongs symptom-free period, might also be a cure].
Olausson M; Friman S; Johanson V; Nilsson O; Wängberg B; Ahlman H
Lakartidningen; 1999 Sep; 96(36):3783-6. PubMed ID: 10500396
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy.
Arvold ND; Willett CG; Fernandez-del Castillo C; Ryan DP; Ferrone CR; Clark JW; Blaszkowsky LS; Deshpande V; Niemierko A; Allen JN; Kwak EL; Wadlow RC; Zhu AX; Warshaw AL; Hong TS
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e337-43. PubMed ID: 22414286
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.
Panzuto F; Nasoni S; Falconi M; Corleto VD; Capurso G; Cassetta S; Di Fonzo M; Tornatore V; Milione M; Angeletti S; Cattaruzza MS; Ziparo V; Bordi C; Pederzoli P; Delle Fave G
Endocr Relat Cancer; 2005 Dec; 12(4):1083-92. PubMed ID: 16322345
[TBL] [Abstract][Full Text] [Related]
39. Standard pre- and postoperative determination of chromogranin a in resectable non-functioning pancreatic neuroendocrine tumors--diagnostic accuracy: NF-pNET and low tumor burden.
Jilesen AP; Busch OR; van Gulik TM; Gouma DJ; Nieveen van Dijkum EJ
Dig Surg; 2014; 31(6):407-14. PubMed ID: 25572908
[TBL] [Abstract][Full Text] [Related]
40. Comparison of neuroendocrine tumor detection and characterization using DOTATOC-PET in correlation with contrast enhanced CT and delayed contrast enhanced MRI.
Giesel FL; Kratochwil C; Mehndiratta A; Wulfert S; Moltz JH; Zechmann CM; Kauczor HU; Haberkorn U; Ley S
Eur J Radiol; 2012 Oct; 81(10):2820-5. PubMed ID: 22236704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]